Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals

Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals

Hemophilia News Today

Image

Please enable the javascript to submit this form

Supported by educational grants from Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc.

Essential SSL